Unlock the potential of pharma-healthtech partnerships with insights from Chiesi Group’s Ameya Phadke, Kaia Health’s Dennis Hermann, and ZS’s Dan Weinstein. Delve into key considerations for effective collaboration, exploring successes and challenges faced by both pharma and healthtech entities. Gain valuable perspectives on entering, maintaining, and managing partnerships, and anticipate future trends in the evolving landscape of pharma-healthtech collaborations.
Partnerships between pharma and healthtech have great potential—but delivering on those partnerships requires overcoming challenges. Expectation and communications can sometimes make effective collaboration difficult. Listen as Ameya Phadke, patient non-pharma solutions leader at Chiesi Group, Dennis Hermann, Head of Europe at Kaia Health and Dan Weinstein, associate principal digital medicine practice lead at ZS, discuss how these partnerships can work successfully and what broader trends they see relating to these partnerships.
You’ll learn more about:
- Key considerations for entering, maintaining and managing partnerships from both pharma and healthtech companies’ points of view
- What works well—and what doesn’t—in these partnerships, and how to collaborate successfully
- The future of pharma-healthtech collaborations
